Injecting the Immune System: Long-Acting TLR7/8 Agonist Shows Promise Against Oral Cancer
A small German cohort study reports that injecting a slow-release TLR7/8 agonist into oral tumors before surgery, combined with systemic ...
A small German cohort study reports that injecting a slow-release TLR7/8 agonist into oral tumors before surgery, combined with systemic ...
Researchers built and validated a nomogram using SEER data from 3,866 patients that predicts cancer-specific survival in laryngeal squamous cell ...
A pilot study found that intratumoral injections of the toll-like receptor 7/8 agonist CB101 combined with hypofractionated radiation therapy were ...
A two-part study of a Texas academic health system finds that clinicians perceive broad head and neck cancer survivorship services, ...
UCLA researchers at the ASTRO 2026 annual meeting present genetic testing, MRI-guided radiation, and radioligand therapy studies aimed at personalizing ...
A new qualitative evidence synthesis identifies five interlocking factors, from perceived clinical value to workflow integration, that determine whether mobile ...
A modelling study published in The Lancet Regional Health – Europe finds that integrating smoking cessation services into NHS cancer ...
Japanese surgeons report a standardized hand-sewn vessel connection technique that reproduces the intima-to-intima benefits of mechanical couplers with zero flap ...
A new review argues that radiomics should serve as a spatial context for biopsy-based biomarkers in head and neck cancer, ...
New research reveals that HGF/c-MET signaling reprograms glutamine metabolism in MET-amplified head and neck cancer cells through ERK-dependent induction of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine